NLRX1 attenuates apoptosis and inflammatory responses in myocardial ischemia by inhibiting MAVS-dependent NLRP3 inflammasome activation
H Li, S Zhang, F Li, L Qin - Molecular Immunology, 2016 - Elsevier
Increasing evidence suggests that inflammation and apoptosis are involved in the
development of acute myocardial ischemia (AMI). Nucleotide-binding oligomerization …
development of acute myocardial ischemia (AMI). Nucleotide-binding oligomerization …
NLRX1 attenuates apoptosis and inflammatory responses in myocardial ischemia by inhibiting MAVS-dependent NLRP3 inflammasome activation.
H Li, S Zhang, F Li, L Qin - Molecular Immunology, 2016 - europepmc.org
Increasing evidence suggests that inflammation and apoptosis are involved in the
development of acute myocardial ischemia (AMI). Nucleotide-binding oligomerization …
development of acute myocardial ischemia (AMI). Nucleotide-binding oligomerization …
NLRX1 attenuates apoptosis and inflammatory responses in myocardial ischemia by inhibiting MAVS-dependent NLRP3 inflammasome activation
H Li, S Zhang, F Li, L Qin - Molecular immunology, 2016 - pubmed.ncbi.nlm.nih.gov
Increasing evidence suggests that inflammation and apoptosis are involved in the
development of acute myocardial ischemia (AMI). Nucleotide-binding oligomerization …
development of acute myocardial ischemia (AMI). Nucleotide-binding oligomerization …
NLRX1 attenuates apoptosis and inflammatory responses in myocardial ischemia by inhibiting MAVS-dependent NLRP3 inflammasome activation
H Li, S Zhang, F Li, L Qin - Molecular Immunology, 2016 - infona.pl
Increasing evidence suggests that inflammation and apoptosis are involved in the
development of acute myocardial ischemia (AMI). Nucleotide-binding oligomerization …
development of acute myocardial ischemia (AMI). Nucleotide-binding oligomerization …